Mostrar el registro sencillo del ítem

dc.contributor.authorLobo, C.*
dc.contributor.authorSantos, T.*
dc.contributor.authorMarques, I.P.*
dc.contributor.authorMadeira, M.H.*
dc.contributor.authorSantos Simoes, Ana Rita*
dc.contributor.authorFigueira, J.*
dc.contributor.authorCunha-Vaz, J.*
dc.date.accessioned2025-09-08T11:50:22Z
dc.date.available2025-09-08T11:50:22Z
dc.date.issued2023
dc.identifier.citationLobo C, Santos T, Marques IP, Madeira MH, Santos AR, Figueira J, et al. Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study. Eye (Basingstoke). 2023;37(2):313-9.
dc.identifier.issn1476-5454
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/6416a4de5db420433b7b5fc2
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21201
dc.description.abstractBackground/objectives: To characterise the prevalence and three-year progression of centre-involving diabetic macular oedema (CI-DMO) in minimal to moderate non-proliferative diabetic retinopathy, using optical coherence tomography (OCT) and measurements of retinal fluid using tissue optical reflectivity ratios (OCT-Leakage). Methods/methods: Seventy-four eyes from 74 patients were followed in a 3-year prospective longitudinal observational cohort of type 2 diabetes (T2D) patients using spectral-domain optical coherence tomography (SD-OCT), OCT-Angiography (OCT-A) and OCT-Leakage (OCT-L). Eyes were examined four times with 1-year intervals. Sixteen eyes (17.8%) were excluded from the analysis due to quality control standards. Retinal oedema was measured by central retinal thickness and retinal fluid by using optical reflectivity ratios obtained with the OCT-L algorithm. Vessel density was measured by OCT-A. Thinning of the ganglion cell and inner plexiform layers (GCL + IPL) was examined to identify retinal neurodegenerative changes. Diabetic retinopathy ETDRS classification was performed using the seven-field ETDRS protocol. Results: CI-DMO was identified in the first visit in 9% of eyes in ETDRS groups 10-20, 10% of eyes in ETDRS group 35 and 15% of eyes in ETDRS groups 43-47. The eyes with CI-DMO and subclinical CI-DMO showed a progressive increase in retinal extracellular fluid during the 3-year period of follow-up. The eyes with CI-DMO and increased retinal extracellular fluid accumulation were associated with vision loss. Conclusions: The prevalence of subclinical CI-DMO and CI-DMO in the initial stages of NPDR occurs independently of severity grading of the retinopathy, showing progressive increase in retinal extracellular fluid and this increase is associated with vision loss (82% 9 out of 11 cases).
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshHumans *
dc.subject.meshMacular Edema *
dc.subject.meshDiabetic Retinopathy *
dc.subject.meshLongitudinal Studies *
dc.subject.meshDiabetes Mellitus, Type 2 *
dc.subject.meshProspective Studies *
dc.subject.meshTomography, Optical Coherence *
dc.titleCharacterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study
dc.typeArtigo
dc.authorsophosLobo, C.; Santos, T.; Marques, I.P.; Madeira, M.H.; Santos, A.R.; Figueira, J.; Cunha-Vaz, J.
dc.identifier.doi10.1038/s41433-022-01937-3
dc.identifier.sophos6416a4de5db420433b7b5fc2
dc.issue.number2
dc.journal.titleEye (Basingstoke)*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)::Xenética
dc.page.initial313
dc.page.final319
dc.relation.publisherversionhttps://doi.org/10.1038/s41433-022-01937-3
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number37


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International (CC BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)